Colorectal cancer-associated fibroblasts (CRC CAFs) are a critical component of the tumor microenvironment, playing pivotal roles in cancer progression, immune evasion, and drug resistance. Our CRC CAFs are isolated from patient-derived colorectal tumor tissues under strict ethical and quality-controlled conditions, offering a reliable in vitro model to study tumor-stroma interactions.

These primary cells retain native phenotypic markers, secretory activity, and ECM-remodeling functions characteristic of in vivo CAF populations. They are ideal for applications in drug screening, immuno-oncology, transcriptomic profiling, and co-culture systems with epithelial tumor cells or immune cell subsets.

Please, inquire for the additional molecular characterisation of the cells and other isogenic cell types.